Genetics of Neonatal Encephalopathy and Related Disorders
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
AgeNot listed
SponsorBoston Children's Hospital
About this trial
Investigators at Boston Children's Hospital are conducting research in order to better understand the genetic factors which may contribute to neonatal encephalopathy (NE) and related disorders. These findings may help explain the broad spectrum of clinical features and outcomes seen in individuals with a history of NE.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Diagnosed with neonatal encephalopathy during the neonatal period as documented in the electronic medical record
Less than 6 years old at the time of study enrollment
Patient at Boston Children's Hospital
Disqualifiers
Genetic cause of NE already identified
Deceased prior to enrollment
Trial population
Patients at Boston Children's Hospital and available biological parents
Trial design
Design model
Cohort
Time perspective
Prospective
Treatments tested in this trial
Not listed
Trial groups
300 Participants
are grouped into 1 trial groupGroup A: Neonatal Encephalopathy
Trial outcomes
Primary outcomes
1
Diagnostic yield
The diagnostic yield of genomic sequencing will be calculated as the percentage of enrolled participants with NE who receive a genetic diagnosis.
Time frame
10 yearsSponsors and contacts
Click on the lead sponsor to view all of their trials.
Source ClinicalTrials.gov